Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry E Goldberg

Showing results (21-30 of 188) with videos related to

Pageof 19
Sort By:
The American Journal of Psychiatry|October 4, 2005
Cognitive control and semantics in schizophrenia: an integrated approachJessica R Cohen, Brita Elvevåg, Terry E Goldberg
Nature Communications|September 19, 2020
Association of APOE e2 genotype with Alzheimer's and non-Alzheimer's neurodegenerative pathologiesTerry E Goldberg, Edward D Huey, D P Devanand
Journal of Neurology, Neurosurgery, and Psychiatry|November 5, 2020
Associations of APOE e2 genotype with cerebrovascular pathology: a postmortem study of 1275 brainsTerry E Goldberg, Edward D Huey, Davangere P Devanand
Journal of Psychiatric Research|January 4, 2025
Preventing disease progression in schizophrenia: What are we waiting forJeffrey A Lieberman, Alana Mendelsohn, Terry E Goldberg, et al.
Journal of Clinical Epidemiology|June 1, 2023
In clinical trials, efficacy vs. effectiveness language is confusingRyan E Lawrence, Adam Bernstein, Chaya Jaffe, et al.
Frontiers in Aging Neuroscience|August 1, 2022
Apolipoprotein E Genotype e2: Neuroprotection and Its LimitsHyun Kim, Davangere P Devanand, Scott Carlson, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeuticsCatherine M Diaz-Asper, Daniel R Weinberger, Terry E Goldberg
Alzheimer Disease and Associated Disorders|February 10, 2026
Associations Among Probable REM-sleep Behavior Disorder, Dopamine Transporter Binding, and Cognitive Performance in Parkinson DiseaseHyun Kim, Yumeng Ada Qi, Terry E Goldberg, et al.
Current Opinion in Neurology|February 17, 2022
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trialsScott Carlson, Hyun Kim, Davangere P Devanand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2023
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trialsTerry E Goldberg, Seonjoo Lee, Davangere P Devanand, et al.
Pageof 19

Showing results (21-30 of 188) with videos related to

Sort By:
Pageof 19
The American Journal of Psychiatry|October 4, 2005
Cognitive control and semantics in schizophrenia: an integrated approachJessica R Cohen, Brita Elvevåg, Terry E Goldberg
Nature Communications|September 19, 2020
Association of APOE e2 genotype with Alzheimer's and non-Alzheimer's neurodegenerative pathologiesTerry E Goldberg, Edward D Huey, D P Devanand
Journal of Neurology, Neurosurgery, and Psychiatry|November 5, 2020
Associations of APOE e2 genotype with cerebrovascular pathology: a postmortem study of 1275 brainsTerry E Goldberg, Edward D Huey, Davangere P Devanand
Journal of Psychiatric Research|January 4, 2025
Preventing disease progression in schizophrenia: What are we waiting forJeffrey A Lieberman, Alana Mendelsohn, Terry E Goldberg, et al.
Journal of Clinical Epidemiology|June 1, 2023
In clinical trials, efficacy vs. effectiveness language is confusingRyan E Lawrence, Adam Bernstein, Chaya Jaffe, et al.
Frontiers in Aging Neuroscience|August 1, 2022
Apolipoprotein E Genotype e2: Neuroprotection and Its LimitsHyun Kim, Davangere P Devanand, Scott Carlson, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
Catechol-O-methyltransferase polymorphisms and some implications for cognitive therapeuticsCatherine M Diaz-Asper, Daniel R Weinberger, Terry E Goldberg
Alzheimer Disease and Associated Disorders|February 10, 2026
Associations Among Probable REM-sleep Behavior Disorder, Dopamine Transporter Binding, and Cognitive Performance in Parkinson DiseaseHyun Kim, Yumeng Ada Qi, Terry E Goldberg, et al.
Current Opinion in Neurology|February 17, 2022
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trialsScott Carlson, Hyun Kim, Davangere P Devanand, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2023
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trialsTerry E Goldberg, Seonjoo Lee, Davangere P Devanand, et al.
Pageof 19